Latin Clinical Trial Center Joins PhaseWell Research to Strengthen Clinical Research Access in Puerto Rico

Latin Clinical Trial Center Becomes Part of PhaseWell Research, Expanding Research and Therapeutic Access PhaseWell Research, a rapidly growing multisite clinical research organization dedicated to expanding access to clinical trials…

Read MoreLatin Clinical Trial Center Joins PhaseWell Research to Strengthen Clinical Research Access in Puerto Rico

Oligomerix Secures $1.9 Million NIH Phase II SBIR Fast-Track Grant to Advance OLX-07010 Toward Alzheimer’s Clinical Trials

Oligomerix Receives $1.9 Million NIH Grant to Advance Oral Tau-Targeting Therapy for Alzheimer’s Disease Oligomerix, Inc., a privately held clinical-stage biotechnology company focused on developing novel treatments for Alzheimer’s disease…

Read MoreOligomerix Secures $1.9 Million NIH Phase II SBIR Fast-Track Grant to Advance OLX-07010 Toward Alzheimer’s Clinical Trials

Deciphera Pharmaceuticals Doses First Patient in Pivotal Phase 3 INTREPID Trial of Sapablursen for Polycythemia Vera

Deciphera Pharmaceuticals Launches Global Phase 3 INTREPID Trial of Sapablursen for Polycythemia Vera Deciphera Pharmaceuticals, a member of Ono Pharmaceutical Co., Ltd., has announced a significant milestone in the development…

Read MoreDeciphera Pharmaceuticals Doses First Patient in Pivotal Phase 3 INTREPID Trial of Sapablursen for Polycythemia Vera

Jazz Pharmaceuticals and AbCellera Partner to Develop Next-Generation T-Cell Engaging Multispecific Antibodies

Jazz Pharmaceuticals and AbCellera Partner to Advance Next-Generation T-Cell Engaging Antibodies for Gastrointestinal and Solid Tumors Jazz Pharmaceuticals and AbCellera have entered into a strategic research collaboration aimed at discovering…

Read MoreJazz Pharmaceuticals and AbCellera Partner to Develop Next-Generation T-Cell Engaging Multispecific Antibodies